Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Abstract People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs, also known as LMW-fluorophores (LMW-F), are associated with risk factors, predict...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrzej S. Januszewski, David Chen, Russell S. Scott, Rachel L. O’Connell, Nanda R. Aryal, David R. Sullivan, Gerald F. Watts, Marja-Riitta Taskinen, Philip J. Barter, James D. Best, R. John Simes, Anthony C. Keech, Alicia J. Jenkins
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/294b7a4d63544e699e028df0d5160f58
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares